Becton, Dickinson Guides FY23 Below Estimates; Boosts Dividend 4.6% - Update

RTTNews | 1089 hari yang lalu
Becton, Dickinson Guides FY23 Below Estimates; Boosts Dividend 4.6% - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) initiated its adjusted earnings and revenue outlook for fiscal 2023.

For fiscal 2023, the company now projects adjusted earnings in a range of $11.85 to $12.10 per share on revenues between approximately $18.6 billion and $18.8 billion, with currency-neutral revenue growth of 5.25 to 6.25 percent. On average, analysts polled by Thomson Reuters expect the company to report earnings of $12.19 per share on revenue grown of 2.90 percent to $19.37 billion for the year. Analysts' estimates typically exclude special items.

Separately, the Board of Directors of BD declared a 4.6 percent higher quarterly dividend of $0.91 per common share, payable on December 30, 2022 to holders of record on December 9, 2022.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
BD Recalls ChloraPrep Clear 1 ML Applicators

BD Recalls ChloraPrep Clear 1 ML Applicators

Medical technology company Becton, Dickinson and Co. or BD has recalled one lot of ChloraPrep Clear 1 mL Applicators citing potential fungal contamination, the U.S. Food and Drug Administration said. Under certain environmental conditions, the contamination allows the growth of Aspergillus penicillioides within the packaging.
RTTNews | 258 hari yang lalu
Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

Becton, Dickinson Boosts FY24 Ad, EPS Outlook - Update

While reporting financial results for the third quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings guidance for fiscal 2024, while trimming annual revenue outlook.
RTTNews | 459 hari yang lalu
BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters

Medical technology company BD or Becton, Dickinson and Co. (BDX) announced Friday the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.
RTTNews | 577 hari yang lalu
BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

BD Gets FDA 510(k) Clearance For Fingertip Blood Collection Device

Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Thursday it has received 510(k) clearances from the U.S. Federal Drug Administration (FDA) for a novel blood collection device that obtains blood samples from a fingerstick that produce lab-quality results for some of the most commonly ordered blood tests.
RTTNews | 697 hari yang lalu
Becton, Dickinson Boosts FY23 Outlook - Update

Becton, Dickinson Boosts FY23 Outlook - Update

While reporting financial results for the second quarter on Thursday, medical technology company Becton, Dickinson and Co. (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews | 914 hari yang lalu
Becton, Dickinson Boosts FY23 Outlook - Update

Becton, Dickinson Boosts FY23 Outlook - Update

While reporting financial results for the first quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) raised its adjusted earnings and revenue outlook for fiscal 2023.
RTTNews | 1005 hari yang lalu
Thai Stock Market May Snap Losing Streak On Tuesday

Thai Stock Market May Snap Losing Streak On Tuesday

The Thai stock market has moved lower in three straight sessions, slumping more than 6 points or 0.5 percent along the way. The Stock Exchange of Thailand now sits just shy of the 1,310-point plateau although it may stop the bleeding on Tuesday.
RTTNews | 1j 19min yang lalu